Benlysta 200 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FJU33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,153
Award facts
- Contract value 100% obligated
- $6,152.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml syringes on September 5, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta (belimumab) is a biologic immunosuppressant used primarily in the treatment of systemic lupus erythematosus, indicating this procurement supports military and federal healthcare programs' therapeutic needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical supplies serving military healthcare systems, the Defense Health Agency, and other government entities. The parent IDC represents a comprehensive global pharmaceutical support vehicle enabling flexible delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support worldwide military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FJU33?
SPE2DB25FJU33 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU33 worth?
The government has obligated $6,153 on SPE2DB25FJU33.
Is contract SPE2DB25FJU33 an order under another contract?
Yes. SPE2DB25FJU33 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU33 competed?
The extent of competition for SPE2DB25FJU33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award